Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Find a Doctor

Caron A. Jacobson, MD, MMSc

Medical Oncology

 Make an Appointment
Watch Video

Caron A. Jacobson, MD, MMSc

Physician

  • Medical Director, Immune Effector Cell Therapy Program
  • Senior Physician
  • Assistant Professor of Medicine, Harvard Medical School

Centers/Programs

Clinical Interests

  • CAR T-cell therapy
  • Lymphoma

Diseases Treated

  • Leukemia, Chronic Lymphocytic (CLL)
  • Lymphoma, Hodgkin
  • Lymphoma, Non-Hodgkin

Contact Information

  • Appointments617-632-5847
  • Office Phone Number617-632-5847
  • Fax617-582-7890
Make an Appointment

Board Certification:

  • Hematology, 2011
  • Internal Medicine, 2007
  • Medical Oncology, 2011

Fellowship:

  • Dana-Farber/Partners CancerCare, Hematology/Oncology

Residency:

  • New York-Presbyterian Hospital, Columbia University College of Physicians & Surgeons, Internal Medicine

Medical School:

  • Columbia University College of Physicians & Surgeons

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions

Ratings

  • Caron A. Jacobson, MD, MMSc
    News Releases
    12/11/2022

    CAR-T-cell shows promise in patients with lymphoma of the brain and spinal cord in early trial

    • CAR T-Cell Therapy
    • Lymphomas
    Publications
    4/15/2021

    Dana-Farber scientists power ongoing innovation in cell therapies for cancer

    • BPDCN
    • Cellular Therapies
    • CAR T-Cell Therapy
    • Immunotherapy
    Caron Jacobson, MD, MMSc
    News Releases
    3/8/2021

    Dana-Farber to offer first CAR T-cell therapy for indolent follicular lymphoma following FDA approval

    • Cellular Therapies
    • CAR T-Cell Therapy
    • Lymphomas
    Caron Jacobson, MD, MMSc
    News Releases
    12/5/2020

    CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma

    • Cellular Therapies
    • CAR T-Cell Therapy
    • Research
    • Non-Hodgkin lymphoma
    _
    News Releases
    12/1/2020

    Dana-Farber to present more than 40 research studies at 2020 ASH Annual Meeting

    • Research
    • Myelodysplastic/Myeloproliferative Diseases
    • Multiple Myeloma
    • Lymphomas
    • Leukemias
    • Blood Cancer
    _
    News Releases
    7/24/2020

    Dana-Farber to offer first CAR T-cell therapy for mantle cell lymphoma following FDA approval

    • CAR T-Cell Therapy
    • Research
    • Lymphomas
    Dana-Farber Cancer Institute
    News Releases
    5/29/2020

    Dana-Farber researchers present key studies at ASCO annual meeting

    • Research
    _
    News Releases
    12/2/2018

    Dana-Farber researchers report clinical trial results in treatment of leukemia and lymphoma

    • CAR T-Cell Therapy
    • Research
    • Lymphomas
    • Leukemias
    Caron A. Jacobson, MD
    News Releases
    5/1/2018

    Dana-Farber/Brigham and Women’s Cancer Center offers CAR T-cell therapy Kymriah™, now approved for lymphoma

    • CAR T-Cell Therapy
    • Lymphomas
Top